Skip to content

The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer

The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02716623
Acronym
DEAL
Enrollment
5
Registered
2016-03-23
Start date
2016-03-31
Completion date
2019-05-01
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Diabetes Mellitus

Brief summary

The purpose of this study is to learn if bladder cancer patients can follow a diet and exercise program during treatment and whether the program will improve results of their treatment.

Detailed description

This study will examine the effects of a carbohydrate restricted (CR) diet in bladder cancer patients with diabetes. The goal of this pilot study is to determine if the CR diet and exercise routine are feasible for this patient population to follow. Participants in this study will receive meals tailored to their specific needs. A registered dietitian will work with them to establish guidelines for the meals and to follow their progress throughout the study. Participants will be asked to be in this study for up to 12 months. A participant will be asked to make a total of 16 in-person visits over the course of 12 months.

Interventions

OTHERCR diet

Diet consists of meals lower in carbohydrates but does not restrict the number of calories that participants can consume.

BEHAVIORALExercise

Participants will be asked to undergo specific exercise schedule. Exercise will be tracked using a fitness device.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of non-muscle-invasive bladder cancer * Have completed Transurethral Resection of Bladder Tumor (TURBT) procedure * Diagnosis of diabetes or pre-diabetes, or use diabetic medication, or show signs of diabetes which would prompt a diabetic screening

Exclusion criteria

* Evidence of muscle-invasion or metastatic disease * BMI less than 18.5 and/or score in the severe malnourished category of the patient generated subjective global assessment (PGSGA) * Unable to complete the exercise regimen or deemed a fall risk * Participating in a research study involving any form of treatment intervention

Design outcomes

Primary

MeasureTime frameDescription
Participant compliance with study specific CR diet12 monthsMeasure participant compliance with CR diet. Compliance will be measured through adherence to study diet. Study team members will regularly check in with participants to track weekly food data.

Secondary

MeasureTime frameDescription
Presence of Tumor M2-PK12 monthsLevel of Tumor M2-PK will be assessed over the course the study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026